Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00059410
Status:
COMPLETED
Last Update Posted:
2009-12-11
First Post:
2003-04-24
Brief Title:
Alzheimers Disease Treatment and Illness Perceptions Survey TIPS II
Sponsor:
Alzheimers Association
Organization:
National Institute on Aging NIA
Study Overview
Official Title:
Alzheimers Disease Treatment and Illness Perceptions Survey TIPS II
Status:
COMPLETED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The TIPS Study or Treatment and Illness Perceptions Survey is a study funded by the national Alzheimers Association to learn more about differences between African Americans and Whites attitudes beliefs and experiences related to Alzheimers disease AD The study involves a one-time 30-minute telephone survey in which participants are asked about a range of topics related to AD including their personal experiences their beliefs about the diseases symptoms and risk factors and their attitude toward possible future treatment options Information from the survey will be used to develop more culturally sensitive health education and healthcare services for persons with AD
Detailed Description:
The main goal of the Boston Universitys TIPS II project is to examine differences in Alzheimers disease AD illness perceptions between African Americans and Whites in order to better understand attitudes and beliefs and to develop more culturally sensitive health services for AD This 30-minute telephone survey will include a total of 140 first-degree relatives and caregivers of people with AD as well as a comparison group of 70 adults without family history The researchers will assess 1 beliefs about AD 2 the perceived threat it poses 3 sources of information about AD 4 knowledge of basic facts about AD 5 appraisal of AD treatments and 6 intentions regarding current and emerging care options Based on preliminary data this study hypothesize that as compared to Whites African Americans will report lower levels of perceived threat fewer sources of information less awareness of facts and less interest in care options Focus group interviews with African American participants will help interpret study findings and inform recommendations for health education interventions
Findings will inform the development of a set of recommendations for AD health educators that will help them tailor their interventions to African Americans Such educational programs promote increased use of assessment treatment and caregiver assistance services Results will also be used as pilot data in a proposal for a national survey of caregivers and relatives This program of research will address a growing need for increased understanding of beliefs knowledge and intentions regarding AD A total of 210 participants are being sought 105 African Americans and 105 Whites Participants who complete the survey will be given a 1000 check plus informational brochures on AD and the latest newsletter from the Boston University Alzheimers Disease Center
Findings will inform the development of a set of recommendations for AD health educators that will help them tailor their interventions to African Americans Such educational programs promote increased use of assessment treatment and caregiver assistance services Results will also be used as pilot data in a proposal for a national survey of caregivers and relatives This program of research will address a growing need for increased understanding of beliefs knowledge and intentions regarding AD A total of 210 participants are being sought 105 African Americans and 105 Whites Participants who complete the survey will be given a 1000 check plus informational brochures on AD and the latest newsletter from the Boston University Alzheimers Disease Center
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| BUMC 2002-308 | None | None | None |
| NIRG-02-3712 | None | None | None |